HDAC11 as a candidate therapeutic target in multiple myeloma.

被引：1
作者：
Distler, Allison
Brayer, Jason B.
Meads, Mark
Sahakian, Eva
Powers, John Joseph
Alsina, Melissa
Nishihori, Taiga
Baz, Rachid C.
Pinilla-Ibarz, Javier
Sotomayor, Eduardo M.
Shain, Kenneth H.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.8029
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8029
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Catalytic Activity of HDAC11 and HDAC8
    Joseph, Caleb G.
    FASEB JOURNAL, 2011, 25
  • [22] New insights into therapeutic targets in multiple myeloma.
    Anderson, Kenneth C.
    CLINICAL CANCER RESEARCH, 2015, 21
  • [23] Elucidating the enzymatic activity of HDAC11
    Yruela, Carlos Moreno
    Galleano, Iacopo
    Madsen, Andreas
    Olsen, Christian
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [24] Sphingolipids as a novel target for the treatment of multiple myeloma.
    Kang, Yubin
    Venketa, Jagadish Kummetha
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [25] Aurora kinases as therapeutic targets in multiple myeloma.
    Reiman, Tony
    Evans, Robert P.
    Naber, Claudia
    Steffler, Tara
    Keats, Jonathan J.
    Perry, Troy
    Maxwell, Christopher A.
    Chau, Heidi
    Belch, Andrew R.
    Pilarski, Linda M.
    BLOOD, 2006, 108 (11) : 254A - 254A
  • [26] Role of HDAC11 in Myogenic Differentiation
    Kim, Hyunmi
    Oh, Kyoung-Jin
    DIABETES, 2017, 66 : LB79 - LB79
  • [27] HDAC11 Inhibition as a Potential Therapeutic Strategy for AML: Target Identification, Lead Discovery, Antitumor Potency, and Mechanism Investigation
    Yang, Maoshuo
    Zhao, Wei
    Zhang, Jinwei
    Liu, Lanlan
    Tian, Sijia
    Miao, Yaqing
    Jia, Yongxin
    Wang, Limei
    Chai, Qipeng
    Wang, Qiang
    Liu, Fabao
    Zhang, Yingjie
    You, Xiaona
    JOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (08) : 8124 - 8142
  • [28] HDAC11: The Lone Mystic Member of Class IV HDAC
    Raina, Shikha
    Kalle, Arunasree M.
    PROCEEDINGS OF THE INDIAN NATIONAL SCIENCE ACADEMY, 2019, 85 (03): : 569 - 576
  • [29] HDAC11 is a regulator of diverse immune functions
    Yanginlar, Cansu
    Logie, Colin
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2018, 1861 (01): : 54 - 59
  • [30] Loss of HDAC11 ameliorates clinical symptoms in a multiple sclerosis mouse model
    Sun, Lei
    Telles, Elphine
    Karl, Molly
    Cheng, Fengdong
    Luetteke, Noreen
    Sotomayor, Eduardo M.
    Miller, Robert H.
    Seto, Edward
    LIFE SCIENCE ALLIANCE, 2018, 1 (05)
12345